Elda Fischi-Gomez1,2,3, Guillaume Bonnier1,2, Pavel Falkowskiy3,4,5, David Romascano3, Myriam Schluep6, Renaud Du Pasquier6, Alessandro Daducci3, Jean-Philippe Thiran3,4, Gunnar Kruger7, and Cristina Granziera1,2
1Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Department of Radiology, Charlestown, MA, United States, 2Harvard Medical School, Boston, MA, United States, 3Signal Processing Laboratory (LTS 5), Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland, 4Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland, 5Advanced Clinical Imaging Technology (HC CMEA SUI DI BM PI), Siemens Healthcare AG, Lausanne, Switzerland, 6Department of Clinical Neurosciences. Neuroimmunology and Neurology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland, 7Siemens Healthcare USA, Malvern, PA, United States
Synopsis
We explored the sensitivity of a novel diffusion MRI
method i.e. “Neurite orientation dispersion and density imaging”, to detect and characterize brain
microstructure alterations in relapsing-remitting multiple sclerosis patients
that we followed up over 2 years. Cross-sectionally, NODDI revealed that an
increase in orientation dispersion and a decrease in neurite density in NAWM
and in lesions of RRMS patients compared to healthy subjects. Longitudinally,
NODDI measured a decreased dispersion and an increased neurite density
in MS lesions at 2 years follow-up. Also, NODDI metrics at baseline were highly
related to cognition at both baseline and follow-up.
Purpose
Multiple
sclerosis (MS) is a chronic
inflammatory and degenerative disease of the central nervous system, characterized
by the presence of focal and diffuse demyelination, gliosis and axonal damage in
both white matter (WM) and grey matter (GM)1. Neurite
orientation dispersion and density imaging (NODDI)
is a recent diffusion imaging technique that uses diffusion gradients of
different strengths to provide novel metrics of axonal and dendrites integrity2. Two previous preliminary works3,4 showed that NODDI is sensitive to
detect brain structural damage in MS patients compared to controls. In this study,
we explore the value of NODDI to investigate the longitudinal remodeling of
axons and neurites in a population of early MS patients.Methods
Thirty-five RRMS patients with less than 5 years disease duration and
20 healthy controls (HC) were enrolled in the study (Table 1); 87% of patients
were on treatment (high-dosage interferon beta and fingolimod) at study entry (time-point
1, tp1) and 97% at 2 years follow-up (time-point 2, tp2). All subjects
underwent disability, motor and cognitive assessment (Table 2) and Magnetic
Resonance Imaging (MRI) at both time-points (Table 3). We performed: (i) tissue segmentation and lobar parcellation
on MPRAGE images using Morphobox5,6;
(ii) manual lesion segmentation on 3DFLAIR, DIR and MP2RAGE images by two
raters by consensus; (iii) MP2RAGE registration to the diffusion space and
application of the resulting transformation matrix to all segmented volumes, masks
and diffusion weighted images (DWI) volumes using Statistical Parametric Mapping toolbox7. To minimize
partial volume (PV) effects, PV was estimated in each DWI by applying an
iterative PV estimation algorithm to the b0 image8. DWIs were fitted to the
NODDI model using the AMICO framework9 to extract the intra-cellular volume
fraction (ICVF), neurite dispersion index (Orientation Dispersion Index (ODI))
and isotropic volume fraction (isoVF) in normal appearing WM (NAWM) and in lesions.
To study the evolution of lesion properties, the lesion mask obtained at tp1
was registered to NODDI maps at tp2 and only lesions > 10 voxels were
considered to minimize PV effects.
At tp1, NODDI metrics in NAWM
of each lobe were compared between RRMS patients and HC using the Hotelling
two-sided permutation test (n=10000 permutations), with age and gender as covariates and correction
for family-wise error rate. The same statistical analysis was used to compare
mean NODDI metrics in lesions with mean NODDI metrics in the WM of HC. For longitudinal
analysis we performed a t-test to assess differences between tp1 and tp2 in mean
ICVF and ODI metrics in NAWM and lesions. At both time points, a GLM model was
performed with mean ICVF and ODI measures at tp1 as predictors and clinical
scores at tp1 and tp2 as random variables, with age, gender, educational years, anxiety and
depression scores as covariates. Clinical scores were adapted using a box-cox
transformation to satisfy the model assumption for normality. Bonferroni correction
was applied to account for multiple comparisons.Results
Results for the cross-sectional
comparison between patients and controls at tp1 are summarized in Table 4. The GLM analysis showed that (i) NAWM-ODI in
the occipital lobe of tp1 was correlated to the SRT-LTS score (p=0.02,
Adjusted-R2=0.32, Leave-one-Out Spearman (LOO-S)=0.43) and to the MSFC
score (p=0.05, Adjusted-R2=0.3, LOO-S=0.37) at tp1; and (ii) NAWM ODI in the parietal and
occipital lobes was correlated with the SRT-LTR score at tp2 (p=0.0018,
Adjusted-R2=0.44, LOO-S=0.59).
The combined analysis of
ODI and ICVF variations in lesions showed a decreased dispersion and an
increased neurite density at 2 years follow-up (Figure 1, p < 0,05).Discussion
NODDI appeared to be sensitive to detect cross-sectional differences between
early RRMS patients and HC and longitudinal changes in patients.
Cross-sectionally, MS patients exhibited an increase in orientation dispersion
and a decrease in neurite density in NAWM and lesions compared to HC. The significant decrease of the ICVF may be
due to axonal loss or damage, whilst the increase of the neural dispersion may
result from cell and axonal loss resulting in increased extracellular space10. Longitudinal analysis showed
subtle changes indicating an increase of neurite dispersion and of intraneurite
volume in lesions, which suggest repair mechanisms in areas of focal damage11.
Future work will extend the current findings to other MS subtypes and
explore the value of NODDI in monitoring disease progression.Acknowledgements
No acknowledgement found.References
[1] Noseworthy JH,
Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med.
Sep 28;343(13):938-52, 2000.
[2] Zhang,
H., Schneider, T., Wheeler-Kingshott, C. A., & Alexander, D. C. NODDI: practical in vivo
neurite orientation dispersion and density imaging of the human brain. NeuroImage,
61(4), 2012
[3] S. Corollone, N. Cawley, F. Prados, S. Ourselin, C. Tur
GOMez, F. Grussu, C. G. Wheeler-Kingshott, D. Miller, A. Thompson, A. Toosy and
O. Cicarelli. Neurite orientation dispersion and density imaging (NODDI) at the
onset of clinically isolated syndroms (CIS): new insights in the early
microstructural brain tissue changes. Neurology, 8 (16); Supplement P4.157,
2015
[4] W. Bronwlee, P. Alves Da Mota, F. Prados, T. Schneider,
M. Cardoso, D. Altman, S. Ourselin, CG Wheeler-Kingshott, O. Cicarelli and D.
Miller. Neurite Orientation Dispersion and Density Imaging (NODDI) Is Sensitive
to Microstructural Damage Related to Disability in Relapse-Onset MS. Neurology,
8 (16); Supplement S41.003, 2015
[5] Roche A., Ribes D.,
Bach-Cuadra M., Krüger G. On the convergence of em-like algorithms for image
segmentation using Markov random fields. Med.
Image Anal. 15(6):830–839,
2011
[6] Schmitter D., Roche A.,
Maréchal B., Ribes D., Abdulkadir A., Bach-Cuadra M., Daducci A., Granziera C.,
Klöppel S., Maeder P., Meuli R., Krueger G., Alzheimer's Disease Neuroimaging
Initiative An evaluation of volume-based morphometry for prediction of mild
cognitive impairment and Alzheimer's disease. Neuroimage
Clin. ,7:7–17, 2015
[7] http://www.fil.ion.ucl.ac.uk/spm/doc/
[8] Roche et al. Partial Volume Estimation in Brain MRI
Revisited. Med Image Comput Comput Assist Interv. 2014.;
[9] A. Daducci,
E.J. Canales-Rodrigues, H. Zhang, T. Dirby, D.C. Alexander and J.-P. Thiran.
“Accelerated microstructure imaging via convex optimization (AMICO) from
diffusion MRI data.” NeuroImage 105:32-44, 2015.
[10] M.H. Barnett, E. Mathey, M. C. Kiernan, J. D Pollard . Axonal damage
in central and peripheral nervous system inflammatory demyelinating diseases:
common and divergent pathways of tissue damage. Curr Opin Neurol Jun;29(3):213-21, 2016
[11] M.
Absinta, P. Sati , DS Reich. Advanced MRI and staging of multiple sclerosis
lesions. Nat Rev Neurol. 2016 Jun;12(6):358-68. doi: 10.1038/nrneurol.2016.59.
Epub 2016 Apr 29.